GSK Proposes Adding OTC Oral Spray To US Smoking Cessation Sector

FDA schedules Nonprescription Drugs Advisory Committee meeting 18 September to consider GSK's NDA for an OTC nicotine oral spray that delivers 1mg per spray.

Smoking_Cessation

GlaxoSmithKline PLC's leading sales in the US OTC smoking cessation category could grow with its proposal for the first mouth spray product to be available Rx or nonprescription in the country.

The Food and Drug Administration has scheduled a Nonprescription Drugs Advisory Committee meeting for 18 September to consider GlaxoSmithKline Consumer...

More from Europe

Haleon Opens Start-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By 

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Haleon Survey Finds Brits Not Paying Enough Attention To Gum Health

 
• By 

Gum health awareness among British consumers could be better, a recent Haleon survey finds.

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By 

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

More from Geography

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By 

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.

Get To Know: UK Women’s Wellness Start-Up GP Nutrition

 
• By 

Meet UK women's health start-up GP Nutrition, run by busy working mother of four Gabriela Peacock, who says she "truly understands the needs of the women who are looking to her for help.”

Stada CEO Has ‘Big Hopes’ For AI-Driven Personalized Healthcare

 
• By 

“Harnessing AI’s astounding abilities to improve people’s lives and relieve overburdened healthcare systems is one of the great opportunities of our time,” argues Stada CEO Peter Goldschmidt in the company's Health Report 2025.